Cargando…
Isolation of recombinant antibodies directed against surface proteins of Clostridium difficile
Clostridium difficile has emerged as an increasingly important nosocomial pathogen and the prime causative agent of antibiotic-associated diarrhoea and pseudomembranous colitis in humans. In addition to toxins A and B, immunological studies using antisera from patients infected with C. difficile hav...
Autores principales: | Shirvan, Ali Nazari, Aitken, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874623/ https://www.ncbi.nlm.nih.gov/pubmed/26991284 http://dx.doi.org/10.1016/j.bjm.2016.01.017 |
Ejemplares similares
-
Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection
por: Péchiné, Séverine, et al.
Publicado: (2018) -
Characterization of Bacteriophages Infecting Clinical Isolates of Clostridium difficile
por: Phothichaisri, Wichuda, et al.
Publicado: (2018) -
High occurrence of Fusobacterium nucleatum and
Clostridium difficile in the intestinal microbiota of colorectal
carcinoma patients
por: Fukugaiti, Márcia H., et al.
Publicado: (2015) -
Analysis of risk factors and clinical manifestations associated with Clostridium difficile disease in Serbian hospitalized patients
por: Predrag, Stojanović
Publicado: (2016) -
Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing
por: Özsoy, Sevim, et al.
Publicado: (2017)